In this webinar, we will hear from two leaders in the pharmaceutical and construction industries on what works and what does not for ERM. These leaders have designed, implemented and maintained enterprise-wide risk management frameworks and programs. In these interviews we discuss some key questions:
- How can you embed ERM into a business seamlessly, so it does not add extra work, or appear ad hoc?
- How can ERM encourage collaboration among divisions and functions?
- What types of approaches, methods and techniques were used to help individuals and teams make good, risk-informed decisions?
- What risk processes and/or practises provided the most insights, and value for leaders, perhaps in different parts, of the organisation?
- What tools or practices did you try and fail with? Looking back, what caused them to fail and what did you learn? Was anything implemented in place of the elements that failed?
- What successes in implementing ERM can you share that have given you, as an ERM practitioner, recognition and value for the ERM profession?
- Given the rapid change that businesses are undergoing today, with Industry 4.0 and new technology, the increasing complexity of organisational eco-systems and different stakeholder demands, is ERM still “fit for purpose”?
Ollie de Boer is an enterprise risk and project management professional who helps organisations improve their approach to managing risk through practical risk management. He has been working with risk data for 10 years, starting at the Ministry of Justice (UK). As the Software Lead at Satarla, he specialises in risk management software advisory services, helping clients to identify technology solutions that meet their needs, source and implement them. He has worked on both large and small scale implementations for organisations in security, agriculture, mining, utilities and financial services.
Gareth Byatt (MBA, BSc), based in Sydney, Australia, works around the world operating as a Risk Consultant since January 2017. He is a Director of Satarla Australia and also owns Risk Insight Consulting, a sole trading business registered in Australia. Prior to 2017, Gareth worked for Lendlease—recent roles being Head of Risk (Asia) during 2015–16, and Group Risk Manager during 2012–15. Gareth’s work today covers working for clients in various industries and in various geographies.
Dr. Michael Malone (PhD) is based in Brussels, Belgium, and is a Partner and Global Head of the Life Sciences Practice at Satarla. Michael is an expert on the pharmaceutical industry, having over 20 years of experience working in the industry, and has had roles of increasing responsibility across the entire value chain.
Michael has held a number of Senior Executive positions in his career, at both Novartis and UCB, including more recently as Vice President, Global Head of Enterprise Risk Management at UCB Biopharma. Michael designed, implemented and led the new Enterprise Risk Management program at UCB and chaired the Corporate Risk Management Committee.